Journal article
Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
Abstract
An overview of eight randomized controlled trials of tissue-type plasminogen activator (Alteplase or Duteplase) and 10 of anisoylated plasminogen streptokinase activator complex (Anistreplase) showed that the odds of early death were reduced by 29% by tissue-type plasminogen activator and 46% by anisoylated plasminogen streptokinase activator complex, with overlapping 95% confidence intervals. Although the beneficial effects of both agents are …
Authors
Held PH; Teo KK; Yusuf S
Journal
Circulation, Vol. 82, No. 5, pp. 1668–1674
Publisher
Wolters Kluwer
Publication Date
11 1990
DOI
10.1161/01.cir.82.5.1668
ISSN
0009-7322